Status
Ongoing
Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.
Status
Ongoing
Classification
Class I
Report Date
June 18, 2025
Termination Date
—